Report cover image

India Anti-Fungal Drugs Market

Publisher BlueWeave Consulting
Published Sep 15, 2025
Length 113 Pages
SKU # BLWC20706854

Description

India Anti-Fungal Drugs Market, By Drug Class (Azoles, Polyenes, Echinocandins, Allylamines, Others); By Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others); By Route of Administration (Oral, Topical, Intravenous); By Region (East India, West India, South India, North India), Trend Analysis, Competitive Landscape & Forecast, 2019–2031India Anti-Fungal Drugs Market Booming to Cross USD 2.9 Billion by 2031

India Anti-Fungal Drugs Market is flourishing primarily due to rising infections, government support, healthcare expansion, and increasing drug innovations.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated India Anti-Fungal Drugs Market size by value at USD 1,543.86 million in 2024. During the forecast period between 2025 and 2031, BlueWeave expects India Anti-Fungal Drugs Market size to boom at a robust CAGR of 9.50%, reaching a value of USD 2,914.11 million by 2031. The expansion of India Anti-Fungal Drugs Market is driven by rising fungal infections due to poor hygiene, increasing immunocompromised populations, and hospital-acquired diseases. The surge in mucormycosis cases post-COVID-19 has intensified demand for effective treatments. Growing awareness among healthcare professionals, improved diagnostic capabilities, and easy access to over-the-counter medications further support market expansion. Additionally, supportive government health initiatives, rising disposable income, and expanding healthcare infrastructure in rural and urban areas contribute to the steady growth of India Anti-Fungal Drugs Market across the country.

Opportunity – Expansion of Generic Drug Manufacturing for Affordability

The expansion of generic drug manufacturing in India has significantly boosted the affordability and accessibility of anti-fungal treatments. Domestic pharmaceutical companies are producing cost-effective alternatives to branded drugs, reducing treatment expenses for patients across income levels. This shift is especially impactful in rural and semi-urban regions, where affordability is crucial. Regulatory support and competitive pricing have encouraged wider adoption of generics, strengthening India’s position as a global hub for affordable anti-fungal drug production. It, in turn, is expected to boost the growth of India Anti-Fungal Drugs Market in the coming years.

Topical Formulations Segment Accounts Largest Market Share

The topical formulations segment is expected to witness the most significant growth in India Anti-Fungal Drugs Market. Their dominance stems from ease of use, minimal systemic side effects, and effectiveness in treating common dermatological fungal infections like dermatophytosis. Topical drugs allow direct application to affected areas, require fewer doses, and are widely available over the counter. Rising awareness, humid climate conditions, and increasing skin-related fungal cases across India further reinforce the popularity of topical anti-fungal treatments.

Impact of Escalating Geopolitical Tensions on India Anti-Fungal Drugs Market

Escalating geopolitical tensions have disrupted global pharmaceutical supply chains, impacting India Anti-Fungal Drugs Market. India imports over 60% of its active pharmaceutical ingredients (APIs), primarily from China. Trade restrictions, tariff uncertainties, and diplomatic strains have increased production costs and delayed drug availability. These challenges push Indian manufacturers to diversify sourcing and invest in domestic API production. While the market remains resilient, prolonged instability could hinder innovation, pricing, and timely access to essential anti-fungal therapies across healthcare settings.

Competitive Landscape

India Anti-Fungal Drugs Market is highly fragmented, with numerous players serving the market. Major companies dominating the market include Sun Pharmaceutical Industries Ltd, Cipla Ltd, Glenmark Pharmaceuticals, Dr. Reddy’s Laboratories, Lupin Ltd, Aurobindo Pharma, Torrent Pharmaceuticals, Zydus Lifesciences Ltd, Alkem Laboratories, Pfizer India, and Abbott India Ltd. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge over their competitors in India Anti-Fungal Drugs Market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and India Anti-Fungal Drugs Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in India Anti-Fungal Drugs Market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

113 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. India Anti-Fungal Drugs Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rising Incidence of Fungal Infections Among Immunocompromised Patients
3.2.1.2. Advancements in Drug Formulations and Combination Therapies
3.2.1.3. Government Initiatives to Improve Access to Essential Medications
3.2.2. Restraints
3.2.2.1. Increasing Resistance to Existing Anti-Fungal Drugs
3.2.2.2. Limited Awareness in Rural and Semi-Urban Areas
3.2.2.3. High Cost of Advanced Anti-Fungal Treatments
3.2.3. Opportunities
3.2.3.1. Expansion of Generic Drug Manufacturing for Affordability
3.2.3.2. Innovation in Novel Anti-Fungal Agents and Delivery Systems
3.2.4. Challenges
3.2.4.1. Difficulty in Designing Selective Anti-Fungal Drugs Due to Human-Fungal Cell Similarity
3.2.4.2. Prevalence of Self-Medication and Misuse Leading to Resistance
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. India Anti-Fungal Drugs Market: Marketing Strategies
5. India Anti-Fungal Drugs Market: Pricing Analysis
6. India Anti-Fungal Drugs Market Overview
6.1. Market Size & Forecast, 2019–2031
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.1.1. Azoles
6.2.1.2. Polyenes
6.2.1.3. Echinocandins
6.2.1.4. Allylamines
6.2.1.5. Others
6.2.2. By Indication
6.2.2.1. Candidiasis
6.2.2.2. Aspergillosis
6.2.2.3. Dermatophytosis
6.2.2.4. Mucormycosis
6.2.2.5. Others
6.2.3. By Route Of Administration
6.2.3.1. Oral
6.2.3.2. Topical
6.2.3.3. Intravenous
6.2.4. By Region
6.2.4.1. East India
6.2.4.2. West India
6.2.4.3. South India
6.2.4.4. North India
7. Competitive Landscape
7.1. List of Key Players and Their Offerings
7.2. Nigeria Insurance Company Market Share Analysis, 2024
7.3. Competitive Benchmarking, By Operating Parameters
7.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
8. Impact of Escalating Geopolitical Tensions on India Anti-Fungal Drugs Market
9. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
9.1. Sun Pharmaceutical Industries Ltd
9.2. Cipla Ltd
9.3. Glenmark Pharmaceuticals
9.4. Dr. Reddy’s Laboratories
9.5. Lupin Ltd
9.6. Aurobindo Pharma
9.7. Torrent Pharmaceuticals
9.8. Zydus Lifesciences Ltd
9.9. Alkem Laboratories
9.10. Pfizer India
9.11. Abbott India Ltd
9.12. Other Prominent Players
10. Key Strategic Recommendations
11. Research Methodology
11.1. Qualitative Research
11.1.1.Primary & Secondary Research
11.2. Quantitative Research
11.3. Market Breakdown & Data Triangulation
11.3.1.Secondary Research
11.3.2.Primary Research
11.4. Breakdown of Primary Research Respondents, By Region
11.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
Figure 1 India Anti-Fungal Drugs Segmentation
Figure 2 India Anti-Fungal Drugs Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2024
Figure 4 India Anti-Fungal Drugs Market Size, By Value (USD Million), 2019–2031
Figure 5 India Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2019–2031
Figure 6 India Anti-Fungal Drugs Market Share, By Indication, By Value, 2019–2031
Figure 7 India Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2019–2031
Figure 6 India Anti-Fungal Drugs Market Share, By Region, By Region, 2019–2031
List of Tables
Table 1 India Anti-Fungal Drugs Market Size, By Value (USD Million), 2019–2031
Table 2 India Anti-Fungal Drugs Market Size, By Drug Class, By Value, 2019–2031
Table 3 India Anti-Fungal Drugs Market Size, By Indication, By Value, 2019–2031
Table 4 India Anti-Fungal Drugs Market Size, By Route of Administration, By Value, 2019–2031
Table 5 India Anti-Fungal Drugs Market Size, By Region, By Value, 2019–2031
Table 6 Sun Pharmaceutical Industries Ltd Company Overview
Table 7 Sun Pharmaceutical Industries Ltd Financial Overview
Table 8 Cipla Ltd Company Overview
Table 9 Cipla Ltd Financial Overview
Table 10 Glenmark Pharmaceuticals Company Overview
Table 11 Glenmark Pharmaceuticals Financial Overview
Table 12 Dr. Reddy’s Laboratories Company Overview
Table 13 Dr. Reddy’s Laboratories Financial Overview
Table 14 Lupin Ltd Company Overview
Table 15 Lupin Ltd Financial Overview
Table 16 Aurobindo Pharma Company Overview
Table 17 Aurobindo Pharma Financial Overview
Table 18 Torrent Pharmaceuticals Company Overview
Table 19 Torrent Pharmaceuticals Financial Overview
Table 20 Zydus Lifesciences Ltd Company Overview
Table 21 Zydus Lifesciences Ltd Financial Overview
Table 22 Alkem Laboratories Company Overview
Table 23 Alkem Laboratories Financial Overview
Table 24 Pfizer India Company Overview
Table 25 Pfizer India Financial Overview
Table 26 Abbott India Ltd Company Overview
Table 27 Abbott India Ltd Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us